Timothy C. Dec - 28 Feb 2026 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Issuer symbol
SUPN
Transactions as of
28 Feb 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 16:11:16 UTC
Previous filing
26 Feb 2026
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEC TIMOTHY C Senior Vice-President & CFO C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE, ROCKVILLE /s/ Timothy C. Dec 03 Mar 2026 0001194020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Award $0 +3,000 $0.000000 3,000 28 Feb 2026 Common Stock 3,000 $0.000000 Direct F1
transaction SUPN Performance Share Unit Award $0 +3,000 $0.000000 3,000 28 Feb 2026 Common Stock 3,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.